The Biostatistics Core will (a) develop and maintain the central database of the SPORE and (b) provide biostatistical expertise for all aspects of the SPORE. The central SPORE database will be web based and will house the clinical, tissue and laboratory data of prostate cancer patients seen at the Northwestern Memorial Hospital and Evanston Northwestern Healthcare sites. Using current data collection systems as a basis, standardized procedures will be developed for collecting, checking, editing, entering, storing, managing and analyzing the SPORE data. The Biostatistics Core will interact extensively with the Clinical and Tissue Cores during the development and operation of the database. This core will have expertise in biostatistics, bioinformatics, database technology, systems programming and data entry. This mix of expertise will house all aspects of data management and analysis into this Core, thereby enhancing the efficiency with which SPORE informatics aspects may be viewed and dealt with on a daily basis. The Biostatistics Core is responsible for developing and maintaining the database, conducting statistical analyses and providing statistical input to study research design. This Core will be available at all times to provide input on design or statistical analysis to all SPORE investigators. This Core will also review procedures for data input and data quality control. Scientific input to the SPORE as a whole will be provided as direct input to the Executive Committee regarding the overall research of the SPORE. Scientific input by the Biostatistics Core will be provided to individual investigators of interpretation of statistical analyses and writing of manuscripts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA090386-02
Application #
6589543
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Hung, Michelle E; Lenzini, Stephen B; Stranford, Devin M et al. (2018) Enrichment of Extracellular Vesicle Subpopulations Via Affinity Chromatography. Methods Mol Biol 1740:109-124
Weiner, Adam B; Tsai, Kyle P; Keeter, Mary-Kate et al. (2018) The Influence of Decision Aids on Prostate Cancer Screening Preferences: A Randomized Survey Study. J Urol 200:1048-1055
Nettey, Oluwarotimi S; Walker, Austin J; Keeter, Mary Kate et al. (2018) Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors. Urol Oncol 36:501.e1-501.e8
Xu, Li; Gordon, Ryan; Farmer, Rebecca et al. (2018) Precision therapeutic targeting of human cancer cell motility. Nat Commun 9:2454
Zhang, Qiang; Helfand, Brian T; Carneiro, Benedito A et al. (2018) Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-? Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease. Eur Urol 73:648-652
Pascal, Laura E; Masoodi, Khalid Z; Liu, June et al. (2017) Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia. J Endocrinol 235:123-136
Dominguez, Donye; Ye, Cong; Geng, Zhe et al. (2017) Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer. J Immunol 198:1365-1375
Murphy, A B; Nyame, Y A; Batai, K et al. (2017) Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy? Prostate Cancer Prostatic Dis 20:55-60
Loeb, Stacy; Shin, Sanghyuk S; Broyles, Dennis L et al. (2017) Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer. BJU Int 120:61-68
Zhang, Minghui; Dominguez, Donye; Chen, Siqi et al. (2017) WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability. Oncol Lett 14:3580-3586

Showing the most recent 10 out of 209 publications